- Home
- CZWI vs CLLS Comparison
CZWI vs CLLS Comparison
Compare CZWI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZWI
- CLLS
- Stock Information
- Founded
- CZWI 1938
- CLLS 1999
- Country
- CZWI United States
- CLLS France
- Employees
- CZWI N/A
- CLLS N/A
- Industry
- CZWI Savings Institutions
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- CZWI Finance
- CLLS Health Care
- Exchange
- CZWI Nasdaq
- CLLS Nasdaq
- Market Cap
- CZWI 149.5M
- CLLS 148.1M
- IPO Year
- CZWI N/A
- CLLS 2007
- Fundamental
- Price
- CZWI $13.59
- CLLS $1.45
- Analyst Decision
- CZWI
- CLLS Buy
- Analyst Count
- CZWI 0
- CLLS 3
- Target Price
- CZWI N/A
- CLLS $7.00
- AVG Volume (30 Days)
- CZWI 22.8K
- CLLS 120.5K
- Earning Date
- CZWI 04-28-2025
- CLLS 05-27-2025
- Dividend Yield
- CZWI 2.66%
- CLLS N/A
- EPS Growth
- CZWI 7.42
- CLLS N/A
- EPS
- CZWI 1.34
- CLLS N/A
- Revenue
- CZWI $59,572,000.00
- CLLS $49,217,000.00
- Revenue This Year
- CZWI N/A
- CLLS $1.26
- Revenue Next Year
- CZWI $12.31
- CLLS N/A
- P/E Ratio
- CZWI $10.14
- CLLS N/A
- Revenue Growth
- CZWI 0.84
- CLLS 435.38
- 52 Week Low
- CZWI $10.14
- CLLS $1.10
- 52 Week High
- CZWI $17.04
- CLLS $3.38
- Technical
- Relative Strength Index (RSI)
- CZWI 44.46
- CLLS 60.38
- Support Level
- CZWI $12.69
- CLLS $1.40
- Resistance Level
- CZWI $13.50
- CLLS $1.56
- Average True Range (ATR)
- CZWI 0.44
- CLLS 0.09
- MACD
- CZWI 0.01
- CLLS 0.03
- Stochastic Oscillator
- CZWI 40.54
- CLLS 76.09
About CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.